癌症免疫治疗中的新抗原:专注于替代拼接
Peng Huang1,2, Feng Wen1,3, Nuerye Tuerhong1,2
1Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Frontiers in immunology
|July 26, 2024
概括
替代拼接 (AS) 产生新抗原,这些新抗原是癌症疫苗和CAR T细胞疗法的有希望的标. 了解AS衍生的新抗原可以在癌症免疫疗法中推进精密医学.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 替代拼接 (AS) 驱动蛋白质组的多样性和蛋白质的功能变化.
- AS产生具有癌症进展和免疫反应预后意义的新抗原.
- 免疫疗法改变了癌症治疗模式.
研究的目的:
- 审查AS衍生的新抗原作为免疫治疗点.
- 引导基于AS衍生的新抗原的免疫疗法策略.
- 探索癌症免疫治疗中精准医学的新视角.
主要方法:
- 关于替代拼接和新抗原的文献评论.
- 在癌症免疫学中分析AS衍生的新抗原.
- 讨论免疫治疗的应用,包括癌症疫苗和CAR T细胞治疗.
主要成果:
- 来自AS的新抗原是癌症疫苗和CAR T细胞治疗的可行的标.
- 这些新抗原具有预后价值,并影响抗癌免疫反应.
- 来自AS的新抗原为蛋白质组多样性和精密医学提供了洞察力.
结论:
- 来自AS的新抗原代表了癌症免疫治疗的有希望的途径.
- 需要进一步的研究来克服临床应用的挑战.
- 这种方法提高了对癌症复杂性和个性化治疗策略的理解.
相关概念视频
Alternative RNA Splicing
21.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.1K
RNA Splicing
56.3K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.3K
Tumor Immunotherapy
501
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
501
Cancer Vaccines
348
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
348
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K


